What Does Surgical Margin Positivity (R0 / R1 / R2) Mean in the Pathology Report? Why is Clean Border Essential?
In this article
Was the Surgery Successful? A Guide to Understanding the "Margin" Line in Your Pathology Report
After cancer surgery, one of the lines people most want to understand in the pathology report is "surgical margins." This line shows whether there are tumor cells at the edge of the removed tissue, in other words, whether the tumor was removed completely along with a rim of healthy tissue around it. In the international R classification, R0 means that no tumor remains even under the microscope, R1 means that the margin looks clear to the eye but tumor is found at the margin under the microscope, and R2 means that visible tumor was left behind. A clear margin (R0) is the most important surgical goal in many cancers, lowering the risk of recurrence and improving the chance of cure; however, a "positive margin" does not always mean the tumor will come back, and how much distance counts as "adequate" depends on the type of cancer. In this guide, we explain what R0/R1/R2 mean, how the pathologist assesses the margin, how this differs by organ and what can be done after a positive margin. We covered other terms found in pathology reports in our article on dysplasia, metaplasia and hyperplasia, and methods of obtaining tissue samples in our article on biopsy.
- What are R0, R1 and R2? R0: no tumor remains; the margins are clear even under the microscope. R1: clear to the eye, but tumor is present at the margin under the microscope. R2: tumor seen by the surgeon could not be removed. RX: cannot be assessed.
- Why does it matter? In many cancers, a positive margin raises the risk of recurrence at the same site; for example, in breast-conserving surgery, a positive margin at least doubles the risk of recurrence within the breast. In rectal, pancreatic, head and neck and esophageal cancers, R1 is associated with a worse course.
- How much is "clear"? It depends on the organ: in invasive breast cancer, "no ink on tumor" is sufficient; in DCIS, 2 mm; in the rectum, a circumferential margin of more than 1 mm; in head and neck cancer, 5 mm or more.
- What happens if the margin is positive? Options include re-operation, radiation therapy, chemoradiotherapy, drug therapy or close monitoring. The decision is made by the tumor board based on the tumor type, which margin is involved and to what extent, and the patient's condition.
Why does this matter?
In most solid tumors, the foundation of cure is complete removal of the tumor. The surgeon removes the tumor together with some of the healthy tissue around it; this rim of healthy tissue is called the "surgical margin." A tumor that appears to have been removed completely to the naked eye may have microscopic extensions reaching the margin. In that case, a few cells left behind can cause a recurrence at the same site months or years later. For this reason, margin status is often decisive in determining whether additional treatments, such as radiation therapy or chemotherapy after surgery, are needed.
On the other hand, keeping the margin wide "at any cost" is not right either. Removing more tissue than necessary can spoil the cosmetic result of breast-conserving surgery, affect speech and swallowing in the head and neck, and impair bowel function in the rectum. In modern oncology, the goal is to achieve the "adequate" margin defined by evidence and, when necessary, to increase the chance of a clear margin by shrinking the tumor with treatment before surgery. Understanding your pathology report is the first step toward taking an informed part in treatment decisions and, if needed, asking for a second opinion.
What does a positive surgical margin mean?
A positive surgical margin means that tumor cells are seen under the microscope on the inked outer surface (the margin) of the tissue removed at surgery, suggesting that tumor may have been left in the body. This is classified as R1. R0 means the margins are clear, while R2 means that visible tumor could not be removed. In most cancers, a positive margin raises the risk of recurrence and may require additional treatment.
R0, R1, R2: The residual tumor classification
The R classification describes whether tumor remains in the patient's body after surgery and is a complementary part of TNM staging. The pathologist's margin assessment and the surgeon's observations during the operation are considered together. If a distant metastasis is left behind, the result is classified as R2 even if the margins of the main tumor are clear (what is metastasis?).
Figure 1 · The residual tumor (R) classification
R0, R1, R2 and RX
Figure 2 · What remained in the body after surgery?
What R0, R1 and R2 mean for the patient
| The phrase in your report | What does it mean? |
|---|---|
| "Surgical margins free of tumor / clear / negative" | No tumor on the inked surface; the closest distance is usually also stated |
| "Closest margin 3 mm (deep margin)" | 3 mm between the tumor and the closest margin; whether this is adequate depends on the organ |
| "Close margin" | The tumor is not at the margin but is closer than the organ-specific safe distance |
| "Margin positive / tumor at ink / tumor at the margin" | R1; which margin (e.g., deep, circumferential, end) is involved matters |
| "Carcinoma in situ / dysplasia at the margin" | Precursor cells, not invasive tumor, at the margin; significance depends on the organ |
| "Focally / extensively positive" | Whether the tumor involves the margin at a small point or over a wide area |
| "Margin could not be assessed" | RX; the specimen arrived fragmented or its orientation is unknown |
How does the pathologist assess the margin?
Margin assessment begins in the operating room. The surgeon marks the orientation of the removed specimen with sutures, for example "short suture superior, long suture lateral." In the pathology laboratory, each surface of the specimen is inked in a different color, so that the color seen under the microscope shows which margin is being examined. The specimen is cut into thin slices like a loaf of bread, samples are taken from the closest points, and the shortest distance between the tumor and the ink is measured under the microscope.
Figure 3 · How does the pathologist see the margin?
Ink, clear, close and positive margins
Figure 4 · Margin assessment in the pathology laboratory
Orientation sutures, ink, slicing and the microscope
- Frozen section: In some operations (e.g., head and neck, pancreas, lung), the surgeon sends a small piece of the margin to the pathologist while the operation is still under way. This sample is frozen and examined within a few minutes; if it is positive, additional tissue can be removed during the same operation.
- Cavity shave margins: In breast-conserving surgery, taking thin additional slices from the walls of the cavity after the tumor is removed can reduce the re-operation rate.
- New technologies: Methods such as intraoperative specimen radiography and ultrasound, fluorescent dyes (e.g., pegulisianine, approved in 2024) and tissue spectroscopy aim to show residual tumor before the operation ends. In the approval study, tumor was found in the additional tissue removed under fluorescence guidance in 7.6% of 357 patients.
- Mohs surgery: In skin cancers, the tumor is removed layer by layer and the entire margin is examined under the microscope during the operation; this achieves a high clear-margin rate with minimal loss of healthy tissue.
What does a "clear margin" mean in each organ?
There is no single "right distance." For each type of cancer, the adequate margin has been defined separately, based on how the tumor spreads, the treatments to be given after surgery and the evidence from clinical trials.
Figure 5 · Organ-specific definitions of a clear margin
Breast, rectum, pancreas, head and neck and melanoma
Breast cancer
In breast-conserving surgery, a positive margin at least doubles the risk of recurrence within the breast. However, the joint guideline published in 2014 showed that in invasive cancers treated with whole-breast radiation after surgery, "no ink on tumor" is sufficient and that wider margins do not meaningfully reduce recurrence. For DCIS, 2 mm is recommended (Is a 2 mm margin necessary in DCIS?). This approach reduced unnecessary re-operations. With a positive margin, re-excision is usually performed; a mastectomy is sometimes needed (breast cancer treatment).
Rectal cancer
In the rectum, the most important margin is the distance from the tumor to the fascia surrounding the fatty tissue called the mesorectum, that is, the circumferential resection margin (CRM). If the tumor is 1 mm or closer to this fascia, the margin is considered positive and the risk of local recurrence rises markedly. This risk can be seen on MRI before surgery; in that case, the tumor is shrunk with preoperative chemoradiotherapy or total neoadjuvant therapy (chemoradiotherapy in rectal cancer). In dMMR rectal cancer, immunotherapy has even made monitoring without surgery possible (dostarlimab).
Figure 6 · The circumferential margin (CRM) in rectal cancer
The mesorectum, the mesorectal fascia and the 1 mm rule
Pancreatic cancer
In pancreatic cancer, the R1 rate depends heavily on how the margin is examined and defined. When all surfaces were sampled systematically and "tumor within 1 mm" was counted as R1, most operations previously considered R0 turned out to be R1. For this reason, R0 rates from different centers cannot be compared unless they use the same definition. Chemotherapy and radiation before surgery can increase the R0 rate (preoperative SBRT in pancreatic cancer, pathologic complete response).
When the definition changes, so does the "positive margin" rate
Cancer of the pancreatic head; R1 rate, % (Esposito, 2008). Nonstandardized examination compared with the 1 mm rule and a standardized protocol at the same hospital.
When the margin was sampled systematically on all surfaces and "tumor within 1 mm" was counted as R1, many operations previously considered R0 turned out to be R1. For this reason, R0 rates from different centers cannot be compared unless they use the same definition.
Esophageal and gastric cancer
In these cancers, R1 resection is associated with shorter survival. In the CROSS trial, preoperative chemoradiotherapy raised the R0 rate from 69% to 92% and prolonged survival. Today, treatment before surgery is standard in locally advanced esophageal and gastric cancers (ESMO 2026 gastric and esophageal cancer guideline).
Treatment before surgery can raise the clear-margin rate
Cancer of the esophagus or gastroesophageal junction, phase 3 CROSS trial: R0 resection rate, %.
Chemoradiotherapy given before surgery shrank the tumor and increased the likelihood of complete removal; in this trial, survival was also prolonged (median from 24.0 to 49.4 months). The effect varies by tumor type and treatment.
Head and neck cancers
A distance of 5 mm or more between the tumor and the margin is considered clear, 1–5 mm close, and tumor or carcinoma in situ at the margin positive. A positive margin, together with spread beyond the lymph node capsule, is the main reason for adding cisplatin to radiation therapy after surgery; in the EORTC 22931 and RTOG 9501 trials, chemoradiotherapy improved local control and survival in these patients (treatment of head and neck cancer).
Prostate cancer
Positive margins are common after radical prostatectomy, but not every positive margin means recurrence. Today, instead of immediate radiation, most patients are closely monitored with PSA; when PSA begins to rise, early salvage radiation therapy is given (biochemical recurrence, radiation therapy after surgery).
Skin cancers, melanoma and sarcomas
In melanoma, the surgical margin is planned in advance according to tumor thickness: 0.5–1 cm of healthy skin is removed for melanoma in situ, 1 cm for thickness up to 1 mm, 1–2 cm for 1–2 mm, and 2 cm for more than 2 mm (melanoma). In soft tissue sarcomas, besides the distance, it also matters whether there is a tissue barrier such as fascia between the tumor and the margin; for tumors attached to a blood vessel or nerve, R1 is sometimes accepted as planned and supplemented with radiation therapy.
Lung cancer
In lung cancer, the bronchial, vascular and chest wall margins are assessed. The International Association for the Study of Lung Cancer (IASLC) proposes the category "uncertain resection" (R-uncertain) when lymph node sampling is inadequate, even if the margins are clear. Chemoimmunotherapy before surgery increases the R0 rate and pathologic complete response (preoperative treatment in lung cancer).
What happens if the margin is positive?
A positive or close margin does not necessarily mean that tumor has been left behind: the cells at the edge may have been destroyed by cautery during surgery or cleared by the immune system. Even so, because it raises the risk of recurrence in most cancers, it calls for an additional step. Which step is chosen depends on the tumor type, which margin is involved (e.g., in breast-conserving surgery, the anterior margin differs from the deep margin facing the chest wall), how extensive the involvement is, whether re-operation is feasible and the patient's overall condition.
Figure 7 · Options after a positive margin
Re-operation, radiation therapy, chemoradiotherapy and monitoring
- To detect residual disease: Postoperative imaging (MRI, PET-CT) and, in some cancers, circulating tumor DNA (ctDNA) blood tests can provide additional information on whether tumor remains in the body (postoperative ctDNA tests).
- Treatment before surgery: In tumors where the chance of a clear margin looks low, the tumor can be shrunk by giving chemotherapy, radiation or immunotherapy before surgery (preoperative immunotherapy).
- In skin cancers: With a positive margin, re-excision or Mohs surgery is usually performed (types of skin cancer).
Questions you can ask your doctor
- Are the margins in my report clear? Is it R0, R1 or R2?
- Which margin is closest to the tumor, and how many millimeters away? Is this distance adequate for my type of cancer?
- Is the positive margin invasive tumor or an in situ (precursor) lesion? Is it focal or extensive?
- Do I need re-operation, radiation therapy or another additional treatment? What are the benefits and risks of the options?
- Would the result have been different if I had received treatment before surgery? Should this be discussed in a similar situation in the future?
- Would it be helpful to get a second opinion on my pathology slides?
- "If the margin is positive, the cancer will definitely come back." No. A positive margin raises the risk of recurrence, but many patients never have a recurrence, with or without additional treatment; in prostate cancer, a large proportion of patients with positive margins never experience a recurrence.
- "If the margin is clear, the cancer is completely gone." Not always. A clear margin reflects local control; cells that have spread through the lymph nodes or the bloodstream can cause recurrence elsewhere. The decision on additional treatment also depends on stage and tumor biology.
- "The wider the excision, the better." Beyond the proven adequate margin, a wider operation in most cancers increases loss of function and appearance without reducing recurrence.
- "A close margin is the same as a positive margin." It is not. The significance of a close margin depends on the organ; in breast cancer, if there is no ink on tumor, additional surgery is usually not needed.
- "The surgeon made a mistake." A positive margin is not always a surgical error. Microscopic extensions cannot be seen by eye, and with tumors attached to vital structures, a wider excision may not be possible.
- In Türkiye, margin status is reported as standard in the pathology reports of cancer operations; however, the reporting format and whether the closest distance is stated can vary from center to center. If the distance is not in your report, you can ask your doctor for it.
- Intraoperative frozen section examination is available in many centers; new methods such as fluorescence-guided margin assessment are used in a limited number of centers.
- Pathology slides and blocks can be requested from the hospital and sent to another pathology center for a second opinion.
- For tumors that may require treatment before surgery (rectal, esophageal, gastric, pancreatic and some breast and lung cancers), it is important that the decision be made by a multidisciplinary tumor board before surgery (colon and rectal cancer, pancreatic cancer).
Frequently Asked Questions
- What do R0, R1 and R2 mean in a pathology report?
- R0 means that no tumor remains after surgery even under the microscope, that is, the margins are clear. R1 means that tumor is found at the margin under the microscope even though the margins look clear to the eye, and R2 means that visible tumor could not be removed. RX is when the margin cannot be assessed.
- Is a positive surgical margin dangerous?
- In most cancers, a positive margin raises the risk of recurrence at the same site; for example, in breast-conserving surgery, this risk at least doubles. However, it does not mean the tumor will definitely come back. The risk can be greatly reduced with additional treatments such as re-operation, radiation therapy or chemoradiotherapy.
- How many millimeters should a clear surgical margin be?
- It depends on the type of cancer. In invasive breast cancer, no ink on tumor is sufficient; in DCIS, 2 mm is recommended. In rectal cancer, the circumferential margin should be more than 1 mm, and in head and neck cancers 5 mm or more. In the pancreas, most centers use the 1 mm rule.
- Is re-operation needed if the margin is positive?
- Not always. Re-operation is common in breast cancer, skin cancer and sarcoma; chemoradiotherapy may be preferred in head and neck cancers, and close monitoring with PSA in prostate cancer. The decision is made by the tumor board based on the tumor type, which margin is involved and the patient's condition.
Glossary
- Surgical margin
- The outer surface of the tissue removed at surgery; the rim of healthy tissue left around the tumor.
- R classification
- A classification showing whether tumor remains in the body after surgery (R0, R1, R2, RX).
- Positive margin
- Tumor present on the inked surface or within the distance defined for the organ.
- Close margin
- A situation in which the tumor is not at the margin but is closer than the distance considered safe.
- Inking
- Coloring the surface of the removed specimen with colored ink so that the margin can be recognized under the microscope.
- Frozen section
- Freezing a tissue sample during surgery and examining it under the microscope within minutes.
- Circumferential resection margin (CRM)
- In rectal cancer, the distance from the tumor to the mesorectal fascia.
- Total mesorectal excision (TME)
- An operation in which the rectum is removed in one piece, together with the surrounding fat and lymph nodes, in the plane of the fascia.
- Neoadjuvant therapy
- Treatment given before surgery to shrink the tumor and increase the chance of a clear margin.
- Mohs surgery
- A layered surgical technique for skin cancers in which the entire margin is examined under the microscope during the operation.
DROZDOGAN Academy Commentary
The "margin" line in a pathology report is one of the most concrete indicators of the oncologic success of an operation. But it is not a grade on its own: its meaning depends on the organ, the tumor biology and the treatments that follow.
⚡ Why it matters
R0 resection is a prerequisite for cure in many cancers, while R1 often determines the decision on additional treatment. When patients understand their report correctly, they can take part in the treatment plan and unnecessary anxiety is reduced.
✅ Strengths
Margin definitions in breast, rectal, head and neck and esophageal cancers have been established by large studies and meta-analyses; randomized trials have shown that treatment before surgery increases the R0 rate.
⚠️ Limitations
Definitions can vary from organ to organ and even from center to center; in the pancreas in particular, the R1 rate depends heavily on the examination method. The fact that a positive margin does not always mean residual tumor can make decisions harder.
🩺 In practice
For tumors with a low likelihood of a clear margin, we plan treatment before surgery at the tumor board; with a positive or close margin, we discuss re-operation, radiation therapy, chemoradiotherapy and monitoring options together with our patient. We consider it important that the report clearly states the closest distance and the involved margin.
❓ Open questions
How much will fluorescence-based and AI-assisted margin assessment during surgery reduce re-operations? Can ctDNA identify which patients with positive margins need additional treatment?
Bottom line: R0 describes a clear margin, R1 microscopic residual tumor and R2 visible residual tumor. A clear margin is the foundation for reducing the risk of recurrence in most cancers; but the "adequate" distance depends on the organ, and a positive margin does not mean certain recurrence. Review your report with your doctor in light of the definition for your type of cancer.
- This article was prepared in October 2026.
- The R classification is based on the UICC/AJCC TNM system; breast cancer margin definitions on the SSO-ASTRO (2014) and SSO-ASTRO-ASCO (2016) guidelines; esophageal data on the CROSS trial; pancreatic data on the 2008 study by Esposito and colleagues; and fluorescence imaging data on the news report of the FDA approval.
- The organ-specific distances given are general guideline values; there may be differences between centers and current guidelines.
- The illustrations are simplified and not to scale. The Academy commentary is our own.
- This article is not medical advice; review your pathology report together with your treatment team.
References
- Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology–American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol 2014;32:1507-1515. doi:10.1200/JCO.2013.53.3935
- Morrow M, Van Zee KJ, Solin LJ, et al. Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. J Clin Oncol 2016;34:4040-4046. doi:10.1200/JCO.2016.68.3573
- van Hagen P, Hulshof MCCM, van Lanschot JJB, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012;366:2074-2084. doi:10.1056/NEJMoa1112088
- Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2:996-999. doi:10.1016/S0140-6736(86)92612-7
- Esposito I, Kleeff J, Bergmann F, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 2008;15:1651-1660. doi:10.1245/s10434-008-9839-8
- Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005;27:843-850. doi:10.1002/hed.20279
- Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002;94:2511-2516. doi:10.1002/cncr.10492
- The ASCO Post. Imaging drug to assist in detection of cancerous tissue following lumpectomy approved. April 2024. ascopost.com
Was this article helpful?
Your feedback helps us improve our content.
